Drugs & Targets Gamida Cell says FDA has granted Breakthrough Therapy Designation to NiCord October 14, 2016Vol.42 No.38
Drugs & Targets NICE recommends Eribulin for locally advanced metastatic breast cancer October 04, 2016Vol.42 No.41
Drugs & Targets Novogen and Genentech enter in commercialization agreement got glioblastoma multiforme drug candidate October 04, 2016Vol.42 No.41
Drugs & Targets Pronai Therapeutics obtains exclusive license to develop and commercialize PNT737 September 30, 2016Vol.42 No.36
Drugs & Targets Multiple Myeloma Research Foundation Contributes Data to NCI Genomic Data Commons September 30, 2016Vol.42 No.36
Drugs & Targets Prix Galien Foundation announces “Discovery of the Decade” nominees September 30, 2016Vol.42 No.36
Drugs & Targets Genomics England Partners with GenomOncology on 100,000 Genomes Project September 30, 2016Vol.42 No.36
Drugs & Targets Boehringer Ingelheim and ViraTherapeutics to collaborate on oncolytic virus therapy platform September 30, 2016Vol.42 No.36
Drugs & Targets Janssen submits supplemental FDA New Drug Application for ibrutinib September 30, 2016Vol.42 No.36
Drugs & Targets Dignity Health, Catholic Health Initiatives Launch Precision Medicine Alliance September 23, 2016Vol.42 No.35
